New vaccine combo aims to rally immune system against tough cancers

This early-phase trial tests a two-step vaccine strategy in adults with advanced colorectal or small bowel cancer that has stopped responding to standard treatments. Participants first receive one vaccine injection, followed by two doses of a second vaccine four weeks apart. The main goals are to find the safest dose and to see if the vaccines can trigger an immune response against the cancer.